Lifecore Biomedical
LFCR
LFCR
104 hedge funds and large institutions have $288M invested in Lifecore Biomedical in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 34
3.33% less ownership
Funds ownership: 94.24% → 90.91% (-3.3%)
Holders
104
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$6.63M | |
| 2 | +$4.43M | |
| 3 | +$2.72M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$1.96M |
| 5 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
+$1.85M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$7.85M | |
| 3 | -$5.95M | |
| 4 |
RA
Royce & Associates
New York
|
-$2.39M |
| 5 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$1.06M |